Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats
Abstract Epirubicin is a chemotherapy agent for hepatocellular carcinoma (HCC). However, the outcome of HCC patients receiving epirubicin remains unsatisfactory. Moreover, our previous study indicated that celecoxib suppresses HCC progression and liver cancer stemness. This study evaluated the poten...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Wiley
2018-06-01
|
| 叢編: | Cancer Medicine |
| 主題: | |
| 在線閱讀: | https://doi.org/10.1002/cam4.1487 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|